For the April 12, 2016 meeting of the FDA's Pediatric Advisory Committee

Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.

Briefing Materials

• MEDTRONIC ACTIVA DYSTONIA THERAPY Labeling, 4/15/2003
• ACTIVA DYSTONIA THERAPY Executive Summary, Initial April 21, 2014
• MEDTRONIC ACTIVA DYSTONIA THERAPY Executive Summary 2nd Annual Update, March 24, 2015
• MEDTRONIC ACTIVA DYSTONIA THERAPY Executive Summary 3rd Annual Update, April 12, 2016
• Presentation: Medtronic’s Activa Neurostimulator for Dystonia Treatment Humanitarian Device Exemption (HDE) H020007

ResourcesForYou

• Products and Briefing Materials for the April 12, 2016 Meeting of the Pediatric Advisory Committee
• 2016 Meeting Materials, Pediatric Advisory Committee